EW SG&A Expense Growth
Edwards Lifesciences · SG&A Expense Growth
EW SG&A Expense Growth
Latest reported16.54%period ending
EW FY SG&A Growth (YoY) (0.00% → 16.54%)
Latest values, visible window
High-resolution chart · PNG
EW sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 16.5437% | |
| 13.0616% | |
| 0.9505% | |
| 4.9896% | |
| 21.3311% | |
| -0.9259% | |
| 14.3528% | |
| 9.7504% | |
| 9.9422% | |
| 5.8561% | |
| -0.8858% | |
| 15.0751% | |
| 5.7889% | |
| 9.7136% | |
| 16.8% | |
| 8.0975% | |
| 5.8677% | |
| 14.9761% | |
| 11.1702% | |
| 7.8291% | |
| 9.0028% | |
| 10.3484% | |
| 27.2049% | |
| 12.266% | |
| -6.0185% | |
| -7.2961% | |
| 0% |